Mohini Health

When is the next results date for Mohini Health?

No Upcoming Board Meetings

Has Mohini Health declared dividend?

Yes, Mohini Health & Hygiene Ltd has declared a 5% dividend, amounting to 0.5 per share, with an ex-date of September 20, 2024. The company has demonstrated strong total returns across various periods, reflecting positive performance in both price appreciation and dividend distribution.

Mohini Health & Hygiene Ltd has declared a 5% dividend.<BR><BR>Dividend Details:<BR>- Percentage announced: 5%<BR>- Amount per share: 0.5<BR>- Ex-date: 20 Sep 24<BR><BR>Dividend Yield: 0.83%.<BR><BR>Total Returns by Period:<BR>In the last 6 months, the price return was 20.63%, with no dividend return, resulting in a total return of 20.63%.<BR><BR>Over the past year, the price return was 5.92%, with a dividend return of 0.90%, leading to a total return of 6.82%.<BR><BR>In the 2-year period, the price return was 10.95%, with a dividend return of 0.94%, resulting in a total return of 11.89%.<BR><BR>For the 3-year period, the price return was 63.88%, with a dividend return of 1.38%, culminating in a total return of 65.26%.<BR><BR>In the last 4 years, the price return was 97.72%, with a dividend return of 1.98%, leading to a total return of 99.7%.<BR><BR>Over the past 5 years, the price return was 244.48%, with a dividend return of 2.89%, resulting in a total return of 247.37%.<BR><BR>Overall, Mohini Health has declared a dividend, and the company has shown strong total returns across all periods, indicating a positive performance in both price appreciation and dividend distribution.

Who are the peers of the Mohini Health?

Mohini Health's peers include Coal India, Doms Industries, Sandur Manganese, and others. In terms of management risk, growth, and capital structure, Mohini Health ranks below average compared to its peers, with a 1-year return of 0.00%.

Peers: The peers of Mohini Health are Coal India, Doms Industries, Sandur Manganese, Navneet Educat., Flair Writing, Sundaram Multi., Anmol India, ANI Integrated, Sameera Agro, and Touchwood Enter.<BR><BR>Quality Snapshot: Excellent management risk is observed at Coal India, Sandur Manganese, and Sameera Agro, while Good management risk is found at Doms Industries and Anmol India. Average management risk is noted for Navneet Educat., Flair Writing, ANI Integrated, and Touchwood Enter., while Below Average management risk is associated with Sundaram Multi. and Mohini Health. Excellent growth is seen at Coal India, Doms Industries, Sandur Manganese, and Sameera Agro, while Good growth is noted for ANI Integrated and Touchwood Enter. Average growth is found at Anmol India, while Below Average growth is observed at Navneet Educat., Flair Writing, and Sundaram Multi., with Mohini Health also showing Below Average growth. Excellent capital structure is present at Coal India, Doms Industries, Sandur Manganese, and Navneet Educat., while Average capital structure is seen at Anmol India and ANI Integrated, and Below Average capital structure is associated with Flair Writing, Sundaram Multi., and Mohini Health.<BR><BR>Return Snapshot: Doms Industries has the highest 1-year return at 32.62%, while Anmol India has the lowest at -51.44%. Mohini Health's 1-year return is 0.00%, which is significantly lower than Doms Industries and higher than Anmol India. Additionally, the six-month returns are negative for Coal India, Sandur Manganese, Anmol India, and Sundaram Multi.

What is the technical trend for Mohini Health?

As of June 5, 2025, Mohini Health's trend is mildly bullish, supported by daily moving averages and the weekly MACD, despite some caution from the monthly MACD and bearish signals from the weekly KST and monthly OBV.

As of 5 June 2025, the technical trend for Mohini Health has changed from sideways to mildly bullish. The weekly MACD is bullish, supporting the positive shift in trend, while the monthly MACD is mildly bearish, indicating some caution. Daily moving averages are bullish, reinforcing the short-term positive outlook. However, the weekly KST and monthly OBV are bearish and mildly bearish, respectively, which suggests underlying weakness. The Bollinger Bands show a bullish stance on the monthly chart, but the weekly indicates sideways movement. Overall, the current stance is mildly bullish, driven primarily by the daily moving averages and the weekly MACD, despite some mixed signals from other indicators.

Who are in the management team of Mohini Health?

As of March 2022, the management team of Mohini Health includes Sarvapriya Bansal (Whole-time Director), Avnish Bansal (Managing Director), Parul Bansal (Director), and several independent directors, along with a Company Secretary. The team features a blend of executive and independent leadership.

As of March 2022, the management team of Mohini Health includes the following individuals:<BR><BR>1. Sarvapriya Bansal - Whole-time Director<BR>2. Avnish Bansal - Managing Director<BR>3. Parul Bansal - Director<BR>4. Mukesh Vyas - Independent Director<BR>5. Siddharth Jain Ashokkumar - Independent Director<BR>6. Arnika Jain - Company Secretary & Compliance Officer<BR>7. Mukul Jain - Independent Director<BR>8. Mahesh Fogla - Independent Director<BR>9. Chandrashekhar Bobra - Independent Director<BR>10. Viral Patel - Executive Director<BR><BR>This team comprises a mix of executive and independent directors, along with a company secretary.

What does Mohini Health do?

Mohini Health and Hygiene Ltd is a micro-cap company operating in the miscellaneous industry, originally founded in 2009 and rebranded in 2017. It has a market cap of INR 106 Cr, with key metrics including a P/E ratio of 18.00 and a dividend yield of 0.86%.

Overview:<BR>Mohini Health and Hygiene Ltd operates in the miscellaneous industry as a micro-cap company.<BR><BR>History:<BR>The company was originally incorporated as Mohini Fibers Private Limited in 2009. It transitioned to a public limited company and changed its name to Mohini Fibers Limited in 2015, before adopting its current name, Mohini Health and Hygiene Limited, in 2017. Revenue and profit data for the latest quarter are not available.<BR><BR>Financial Snapshot:<BR>Most recent Net Sales: N/A<BR>Most recent Net Profit: N/A<BR>Market-cap value: INR 106 Cr (Micro Cap)<BR><BR>Key Metrics:<BR>P/E: 18.00<BR>Industry P/E: 32<BR>Dividend Yield: 0.86%<BR>Debt-Equity: 0.17<BR>Return on Equity: 5.90%<BR>Price to Book: 1.05<BR><BR>Contact Details:<BR>Address: 401 Princess Business Sky Park, Scheme No 54 Opp Orbit Mall Indore Madhya Pradesh : 452001<BR>Tel: 91-731-4010051-57<BR>Email: avnish@mohinifibers.com<BR>Website: http://www.mohinihealthandhygiene.com

Who are the top shareholders of the Mohini Health?

The top shareholder of Mohini Health is Avnish Bansal, who owns 56.03% of the company. The highest public shareholder is Akshyesh Arya with 2.77%, while individual investors hold a combined 24.39%.

The top shareholders of Mohini Health are primarily the promoters, with Avnish Bansal holding the largest share at 56.03%. There are no pledged promoter holdings, and the company does not have any mutual funds or foreign institutional investors (FIIs) holding shares. The highest public shareholder is Akshyesh Arya, who owns 2.77% of the company. Additionally, individual investors collectively hold 24.39% of the shares.

How big is Mohini Health?

As of 24th July, Mohini Health & Hygiene Ltd has a market capitalization of 104.00 Cr, classifying it as a Micro Cap company. Shareholder's Funds are valued at 100.38 Cr, and Total Assets amount to 139.73 Cr, but recent quarterly performance data is unavailable.

As of 24th July, Mohini Health & Hygiene Ltd has a market capitalization of 104.00 Cr, categorizing it as a Micro Cap company.<BR><BR>Recent quarterly performance data is not available, so there are no figures for Net Sales or Net Profit for the latest four quarters.<BR><BR>In the balance sheet snapshot for the reporting period ending March 2024, Shareholder's Funds are valued at 100.38 Cr, and Total Assets amount to 139.73 Cr.

How has been the historical performance of Mohini Health?

Mohini Health's historical performance shows a decline in net sales from INR 199.61 crore in March 2024 to INR 167.77 crore in March 2025, despite some improvements in profit metrics. The consolidated net profit dropped significantly to INR 5.85 crore in March 2025, raising concerns about revenue generation capabilities.

Answer:<BR>The historical performance of Mohini Health shows a mixed trend in its financial metrics over the years.<BR><BR>Breakdown:<BR>Mohini Health's net sales have decreased from INR 199.61 crore in March 2024 to INR 167.77 crore in March 2025, following a peak of INR 192.01 crore in March 2023. The total operating income mirrored this decline, dropping to INR 167.77 crore in March 2025 from INR 199.61 crore in the previous year. The company's total expenditure also decreased to INR 156.09 crore in March 2025 from INR 185.67 crore in March 2024. Consequently, the operating profit (PBDIT) increased slightly to INR 22.60 crore in March 2025, compared to INR 21.89 crore in March 2024. Profit before tax rose to INR 14.67 crore in March 2025 from INR 13.34 crore in March 2024, while profit after tax increased to INR 12.04 crore from INR 10.69 crore. However, the consolidated net profit saw a significant drop to INR 5.85 crore in March 2025 from INR 10.69 crore in March 2024, influenced by extraordinary items. The company's total assets increased to INR 167.81 crore in March 2025 from INR 139.73 crore in March 2024, while total liabilities also rose to INR 167.81 crore from INR 139.73 crore. Cash flow from operating activities improved to INR 30.00 crore in March 2025 from INR 14.00 crore in March 2024, indicating better operational efficiency. Overall, while some profit metrics showed improvement, the decline in net sales and net profit raises concerns about the company's revenue generation capabilities.

Is Mohini Health overvalued or undervalued?

As of November 18, 2025, Mohini Health is considered overvalued with a PE Ratio of 12.76 and an EV to EBITDA of 9.50, reflecting a shift to an expensive valuation grade, especially in comparison to peers like Altius Telecom, while its year-to-date return of -19.34% significantly underperforms the Sensex's gain of 9.58%.

As of 18 November 2025, Mohini Health's valuation grade has moved from fair to expensive, indicating a shift in perception regarding its market value. The company is currently considered overvalued. Key ratios include a PE Ratio of 12.76, an EV to EBIT of 15.89, and an EV to EBITDA of 9.50, which suggest that the company's earnings and cash flow metrics do not justify its current price level.<BR><BR>When compared to peers, Mohini Health's PE Ratio of 12.76 is significantly lower than that of Altius Telecom, which boasts a PE of 51.84, highlighting the disparity in valuation among companies in the sector. Additionally, while Mohini Health's EV to EBITDA stands at 9.50, it is still less favorable compared to the higher valuations of its peers. The recent performance of Mohini Health has been underwhelming, with a year-to-date return of -19.34%, contrasting sharply with the Sensex's gain of 9.58%, further reinforcing the notion that the stock is overvalued.

Which are the latest news on Mohini Health?

Why is Mohini Health & Hygiene Ltd falling/rising?

As of 12-Feb, Mohini Health & Hygiene Ltd's stock price is at 40.15, down 3.25%, and has underperformed its sector by 1.8%. The stock has declined 38.51% over the past year, indicating a bearish trend and reduced investor participation.

As of 12-Feb, Mohini Health & Hygiene Ltd's stock price is falling, currently at 40.15, which reflects a decrease of 1.35 or 3.25%. The stock has underperformed its sector by 1.8% today, indicating weaker performance relative to its peers. Over the past week, the stock has declined by 4.40%, while the benchmark Sensex has increased by 0.64%, further highlighting its underperformance.<BR><BR>Additionally, the stock's delivery volume has significantly decreased, with a reported drop of 87.34% against the 5-day average, suggesting a decline in investor participation. Although the stock is trading above its 20-day and 50-day moving averages, it is below its 5-day, 100-day, and 200-day moving averages, which may indicate a bearish trend. <BR><BR>In the longer term, the stock has experienced a substantial decline of 38.51% over the past year, contrasting sharply with the Sensex's gain of 11.98% during the same period. This long-term underperformance, combined with today's negative indicators, contributes to the current downward movement in the stock price.